Epstein‐Barr virus (EBV) has long been suggested as a pathogen in multiple sclerosis (MS).
Here, we used high‐throughput sequencing to determine the diversity …

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central
nervous system of unknown etiology. We tested the hypothesis that MS is caused by Epstein …

This review of the considerable evidence linking Epstein–Barr virus (EBV) infection to risk
and disease progression in multiple sclerosis (MS) builds on the background to the virus …

The aetiology and pathogenesis of MS are unknown, but environmental agents, genetic
susceptibility and stochastic events are likely to be involved. In order to evaluate the …

Objective: To determine whether the activation of innate immune responses, which can be
elicited by pathogenic and endogenous triggers, is associated with the presence of Epstein …

Gray matter lesions are thought to play a key role in the progression of disability and
cognitive impairment in multiple sclerosis (MS) patients, but whether gray matter damage is …

Multiple sclerosis (MS) is a demyelinating disease of the CNS. Epstein-Barr virus (EBV)
contributes to the MS pathogenesis because high levels of EBV EBNA 386–405-specific …

Background: Previous reports indicate an association between Epstein-Barr virus (EBV)
antibody levels and multiple sclerosis (MS) disease activity, but the results have been …

Multiple sclerosis (MS) is a heterogenous autoimmune disease in which autoreactive
lymphocytes attack the myelin sheath of the central nervous system. B lymphocytes in the …

Objective: Elevated levels of anti-EBNA-1 antibodies and infectious mononucleosis (IM)
history have consistently been associated with multiple sclerosis (MS) risk. We aimed to …